Auna S.A.'s SEC filings document a foreign private issuer operating a healthcare services and health-plan platform in Mexico, Peru and Colombia. Current reports on Form 6-K furnish press releases, IFRS financial statements, operating KPIs, annual Form 20-F availability, and updates on healthcare services in Peru, Colombia and Mexico and Oncosalud Peru.
The filing record also covers capital-structure matters, including senior secured notes and completed debt refinancing, as well as material project and agreement disclosures related to the Torre Trecca public-private partnership. These documents frame Auna's results, leverage, segment activity and corporate reporting obligations under its NYSE-listed issuer structure.
AUNA S.A. executive Pablo Cervera, Gerente General Colombia, reported his initial equity position in the company. He directly holds 3,141 Class A common shares, which a footnote explains reflect shares underlying outstanding restricted share units.
He also holds share options over 15,000 Class A common shares at an exercise price of $12.0000 per share, expiring on March 21, 2029, vesting annually in four equal installments beginning on March 21, 2025. A second option covers 26,000 Class A common shares at $6.3200 per share, expiring on July 11, 2035, vesting annually in four equal installments beginning on July 11, 2026.
AUNA S.A. executive Carlos Puyo, Head of Human Resources, reported his initial equity holdings. He directly holds 5,091 Class A common shares, including 3,591 shares underlying restricted share units. He also holds options over 20,000 shares at an exercise price of $12.00 expiring on March 21, 2029, and options over 29,500 shares at $6.32 expiring on July 11, 2035, with both option grants vesting in four equal annual installments from their respective start dates.
AUNA S.A. director Luis Felipe Pinillos Casabonne filed an initial Form 3 showing his ownership in the company’s shares. He directly holds 1,500 Class A Common Shares and 4,007,817 Class B Common Shares. He also has an indirect interest in 4,983 Class A Common Shares held by his spouse.
The Class B Common Shares are convertible into Class A Common Shares on a one-for-one basis, either at the holder’s option or automatically upon certain non-permitted transfers, as described in the company’s articles of association. This filing establishes his starting ownership position as an insider.
AUNA S.A. filed an initial ownership report for Chief Accounting Officer Ursula Heredia. The filing shows she directly holds 6,956 Class A Common Shares. This position includes 3,945 common shares underlying outstanding restricted share units, reflecting a mix of current shares and equity-based compensation.
AUNA S.A. General Counsel Edgardo Cavalie filed an initial Form 3, which is a statement of beneficial ownership for company insiders. The provided data shows no reported transactions, exercises, gifts, or restructuring entries, indicating this filing is purely administrative disclosure rather than a new trading event.
AUNA S.A. director Andrew Soussloff filed an initial ownership report showing holdings of 67,548 Class A common shares. This Form 3 does not reflect a new trade, but documents his existing equity position in the company.
A footnote explains that this total includes 21,299 common shares underlying outstanding restricted share units, which are stock-based awards that can settle in shares over time. All reported holdings are listed as directly owned.
AUNA S.A. director Jorge Basadre filed an initial beneficial ownership report on Form 3 indicating he does not beneficially own any securities of the company. The filing identifies his relationship as a director and is signed by attorney-in-fact Carolina Brovelli as of 03/18/2026.
AUNA S.A. director Oscar Leonardo Bacherer Fastoni filed an initial Form 3 reporting his status as a director of the company. The filing does not list any reportable transactions or derivative positions, and the transaction summary shows no buys, sells, exercises, gifts, or other changes in holdings.
AUNA S.A. director Robert Oberrender filed an initial statement of beneficial ownership on Class A Common Shares. He reports holding 67,548 Class A Common Shares directly. A footnote explains this total includes 21,299 common shares underlying outstanding restricted share units, showing both owned shares and equity-based awards.
Auna S.A. reported FY25 revenue of S/4,385 million, essentially flat year-over-year, while Adjusted EBITDA fell 8% to S/917 million with a 20.9% margin. Despite softer profitability, Adjusted Net Income more than doubled to S/336 million and free cash flow rose 35% versus 2024.
Peru led growth with 9% higher revenue and 14% Adjusted EBITDA growth, supported by strong oncology performance and improved medical loss ratios. Colombia grew revenue 5% but saw lower margins after 2024 one-offs. Mexico’s revenue declined 13% and Adjusted EBITDA 26% for the year, though oncology volumes and early 2026 trends show recovery signs.
The company completed a US$825 million refinancing, keeping net leverage at 3.6x Net Debt-to-Adjusted EBITDA and lifting cash to S/335 million. For 2026, Auna guides to roughly 12% FX-neutral growth in both revenue and Adjusted EBITDA, within a 10–14% range, and plans to hold capex near 4% of revenue.